Literature DB >> 3096681

Diazepam and methadone blood levels following concurrent administration of diazepam and methadone.

K L Preston, R R Griffiths, E J Cone, W D Darwin, C W Gorodetzky.   

Abstract

Results of a previous study indicated that the opioid effects of methadone were enhanced by the concurrent administration of diazepam in methadone-maintained subjects. To determine whether a pharmacokinetic interaction might account for this methadone-diazepam interaction, the plasma levels of methadone, diazepam and diazepam metabolites were determined in blood samples collected during that study. Five adult male patients on methadone maintenance (50-60 mg/day) were administrated single doses of placebo, diazepam (20 and 40 mg), methadone (100%, 150% and 200% of the maintenance dose), and four diazepam-methadone dose combinations (20 and 40 mg diazepam in combination with 100% and 150% of the maintenance dose). The results showed that the concurrent administration of methadone and diazepam did not significantly change the time-course or areas under the plasma concentration-time curve of methadone, diazepam or N-desmethyl-diazepam compared to the levels following the administration of either drug alone. Thus, plasma drug level analysis does not indicate a pharmacokinetic interaction between diazepam and methadone.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096681     DOI: 10.1016/0376-8716(86)90051-7

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  9 in total

1.  Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data?

Authors:  Kiyomi Ito; Koji Chiba; Masato Horikawa; Michi Ishigami; Naomi Mizuno; Jun Aoki; Yasumasa Gotoh; Takafumi Iwatsubo; Shin-ichi Kanamitsu; Motohiro Kato; Iichiro Kawahara; Kayoko Niinuma; Akiko Nishino; Norihito Sato; Yuko Tsukamoto; Kaoru Ueda; Tomoo Itoh; Yuichi Sugiyama
Journal:  AAPS PharmSci       Date:  2002

Review 2.  Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.

Authors:  Chin B Eap; Thierry Buclin; Pierre Baumann
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4.

Authors:  D J Foster; A A Somogyi; F Bochner
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

Review 4.  Indicators of buprenorphine and methadone use and abuse: what do we know?

Authors:  Jane Carlisle Maxwell; Elinore F McCance-Katz
Journal:  Am J Addict       Date:  2010 Jan-Feb

Review 5.  Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review.

Authors:  Elinore F McCance-Katz; Lynn E Sullivan; Srikanth Nallani
Journal:  Am J Addict       Date:  2010 Jan-Feb

6.  Parent and Metabolite Opioid Drug Concentrations in Unintentional Deaths Involving Opioid and Benzodiazepine Combinations.

Authors:  Marcia D Fields; Marie A Abate; Lan Hu; D Leann Long; Matthew L Blommel; Nabila A Haikal; James C Kraner
Journal:  J Forensic Sci       Date:  2015-07       Impact factor: 1.832

7.  Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: a transnational study.

Authors:  Richard Hallinan; Séverine Crettol; Kingsley Agho; John Attia; Jacques Besson; Marina Croquette-Krokar; Robert Hämmig; Jean-Jacques Déglon; Andrew Byrne; John Ray; Andrew A Somogyi; Chin B Eap
Journal:  Eur J Clin Pharmacol       Date:  2009-07-29       Impact factor: 2.953

Review 8.  Polydrug abuse: a review of opioid and benzodiazepine combination use.

Authors:  Jermaine D Jones; Shanthi Mogali; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2012-08-02       Impact factor: 4.492

9.  Warnings Unheeded:The Risks of Co-Prescribing Opioids and Benzodiazepines.

Authors:  Shanna Babalonis; Sharon L Walsh
Journal:  Pain Clin Updates       Date:  2015-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.